Nutex Health (NUTX) Expected to Announce Earnings on Thursday

Nutex Health (NASDAQ:NUTX) will likely be posting its Q4 2025 results after the market closes on Thursday, March 5th. Analysts expect Nutex Health to post earnings of $5.56 per share and revenue of $258.8160 million for the quarter. Investors can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Friday, March 6, 2026 at 10:30 AM ET.

Nutex Health Trading Down 4.8%

NASDAQ:NUTX opened at $111.90 on Wednesday. The business’s 50-day moving average is $140.90 and its two-hundred day moving average is $124.78. The firm has a market capitalization of $791.13 million, a PE ratio of 6.05 and a beta of 0.03. Nutex Health has a 12 month low of $40.67 and a 12 month high of $193.07. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.20 and a quick ratio of 3.18.

Analyst Ratings Changes

NUTX has been the topic of a number of analyst reports. Wall Street Zen upgraded shares of Nutex Health from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 28th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nutex Health in a research report on Monday, December 29th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, Nutex Health has a consensus rating of “Moderate Buy” and an average price target of $252.50.

Institutional Trading of Nutex Health

A number of institutional investors and hedge funds have recently modified their holdings of the business. Deutsche Bank AG grew its position in shares of Nutex Health by 3.9% during the 4th quarter. Deutsche Bank AG now owns 2,633 shares of the company’s stock valued at $433,000 after buying an additional 98 shares during the last quarter. Russell Investments Group Ltd. boosted its stake in Nutex Health by 1.4% in the fourth quarter. Russell Investments Group Ltd. now owns 8,706 shares of the company’s stock valued at $1,433,000 after acquiring an additional 116 shares during the period. First Trust Advisors LP boosted its stake in Nutex Health by 2.4% in the fourth quarter. First Trust Advisors LP now owns 11,461 shares of the company’s stock valued at $1,887,000 after acquiring an additional 272 shares during the period. BNP Paribas Financial Markets grew its holdings in shares of Nutex Health by 966.7% during the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after purchasing an additional 290 shares during the last quarter. Finally, Royal Bank of Canada raised its position in shares of Nutex Health by 752.4% during the 4th quarter. Royal Bank of Canada now owns 358 shares of the company’s stock worth $59,000 after purchasing an additional 316 shares during the period. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.